135 related articles for article (PubMed ID: 26025260)
1. 2015 American Thoracic Society International Conference.
Akkermans R
Lancet Respir Med; 2015 Jul; 3(7):513-5. PubMed ID: 26025260
[No Abstract] [Full Text] [Related]
2. Cystic fibrosis drug is not cost effective, says NICE.
Gulland A
BMJ; 2016 Jun; 353():i3409. PubMed ID: 27325384
[No Abstract] [Full Text] [Related]
3. Precision Medicine: At What Price?
Ferkol T; Quinton P
Am J Respir Crit Care Med; 2015 Sep; 192(6):658-9. PubMed ID: 26207804
[No Abstract] [Full Text] [Related]
4. Radical new treatments for cystic fibrosis.
Arch Dis Child; 2015 Aug; 100(8):727. PubMed ID: 26078470
[No Abstract] [Full Text] [Related]
5. Lumacaftor-ivacaftor (Orkambi) for cystic fibrosis: behind the 'breakthrough'.
Mayer M
Evid Based Med; 2016 Jun; 21(3):83-6. PubMed ID: 26718821
[No Abstract] [Full Text] [Related]
6. [Combined administration of lumacaftor and ivacaftor as a causal therapeutic approach].
Desch M
Med Monatsschr Pharm; 2016 Jan; 39(1):42-4. PubMed ID: 26975180
[No Abstract] [Full Text] [Related]
7. [Causal therapy is available].
Meißner T
MMW Fortschr Med; 2016 Jun; 158(12):74. PubMed ID: 27324018
[No Abstract] [Full Text] [Related]
8. FDA moves on breakthrough therapies.
Fox JL
Nat Biotechnol; 2013 May; 31(5):374. PubMed ID: 23657379
[No Abstract] [Full Text] [Related]
9. [Cystic Fibrosis: toward a genetic treatment; Clostridium difficile versus Clostridium difficile].
Nau JY
Rev Med Suisse; 2015 May; 11(476):1210-1. PubMed ID: 26182641
[No Abstract] [Full Text] [Related]
10. Lumacaftor/ivacaftor for patients homozygous for Phe508del-CFTR: should we curb our enthusiasm?
Jones AM; Barry PJ
Thorax; 2015 Jul; 70(7):615-6. PubMed ID: 26071414
[No Abstract] [Full Text] [Related]
11. A combination therapy for cystic fibrosis.
Brodsky JL; Frizzell RA
Cell; 2015 Sep; 163(1):17. PubMed ID: 26406363
[TBL] [Abstract][Full Text] [Related]
12. 2016 American Thoracic Society International Conference.
Akkermans R
Lancet Respir Med; 2016 Jul; 4(7):538-539. PubMed ID: 27237062
[No Abstract] [Full Text] [Related]
13. Lumacaftor/ivacaftor (Orkambi) for cystic fibrosis.
Med Lett Drugs Ther; 2016 Mar; 58(1491):41-2. PubMed ID: 27027688
[No Abstract] [Full Text] [Related]
14. New Drugs 2019, part 1.
Hussar DA
Nursing; 2019 Feb; 49(2):28-36. PubMed ID: 30676555
[TBL] [Abstract][Full Text] [Related]
15. Update in Cystic Fibrosis 2014.
Ong T; Ramsey BW
Am J Respir Crit Care Med; 2015 Sep; 192(6):669-75. PubMed ID: 26371812
[No Abstract] [Full Text] [Related]
16. Vertex CF data wow Wall Street.
Nat Biotechnol; 2017 Sep; 35(9):807. PubMed ID: 28898228
[No Abstract] [Full Text] [Related]
17. Remarkable progress toward new treatments for cystic fibrosis.
Eldredge LC; Ramsey BW
Lancet Respir Med; 2014 Dec; 2(12):962-4. PubMed ID: 25466347
[No Abstract] [Full Text] [Related]
18. Game Changers.
Ulster Med J; 2015 Oct; 84(3):218-9. PubMed ID: 26668427
[No Abstract] [Full Text] [Related]
19. Update on new pulmonary therapies.
Retsch-Bogart GZ
Curr Opin Pulm Med; 2009 Nov; 15(6):604-10. PubMed ID: 19696677
[TBL] [Abstract][Full Text] [Related]
20. Cystic fibrosis drug Vertex's latest triumph.
Ledford H
Nat Biotechnol; 2012 Mar; 30(3):201-2. PubMed ID: 22398597
[No Abstract] [Full Text] [Related]
[Next] [New Search]